{"entity":{"id":"katz-artur","kind":"person","name":"Artur Katz","aka":[],"tldr":"Artur Katz is a senior São Paulo oncologist and long-time leader of the Sírio-Libanês oncology centre.","summary":"Artur Katz is a medical oncologist at the Oncology Center of Hospital Sírio-Libanês in São Paulo, where he has long led the oncology centre. He specialises in breast cancer, medical oncology and clinical trials, taking part in Brazilian and international breast cancer studies and cooperative groups. His publications include a review of survival endpoints across recent randomised trials in advanced breast cancer and a report of real-world outcomes for patients with HR-positive, HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors at a Brazilian reference centre. He remains one of the senior figures in Brazilian breast oncology.","asOf":"2026-09-08","links":[{"label":"Hospital Sírio-Libanês","url":"https://www.hospitalsiriolibanes.org.br"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Katz%20A%5BAuthor%5D%20Sirio-Libanes%20oncology"}],"tags":[],"related":[],"cancers":["breast-hr-positive"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["sirio-libanes"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["cancer-treatment-and-research-communications"],"dependsOn":[],"notes":[],"role":"Medical oncologist; Oncology Center, Hospital Sírio-Libanês","institutionId":"sirio-libanes","specialisms":["Breast cancer","Medical oncology","Clinical trials"],"profiles":[{"label":"Hospital Sírio-Libanês","url":"https://www.hospitalsiriolibanes.org.br"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Katz%20A%5BAuthor%5D%20Sirio-Libanes%20oncology"}],"papers":[{"title":"Overall Survival and Post-Progression Survival in Advanced Breast Cancer: A Review of Recent Randomized Clinical Trials","journal":"Journal of Clinical Oncology","year":2010,"doi":"10.1200/jco.2009.25.5414"},{"title":"Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil","journal":"Cancer Treatment and Research Communications","year":2023,"doi":"10.1016/j.ctarc.2023.100683"}]},"route":"/people/katz-artur/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"}],"institution":[{"id":"sirio-libanes","kind":"institution","name":"Hospital Sírio-Libanês","route":"/institutions/sirio-libanes/"}],"journal":[{"id":"cancer-treatment-and-research-communications","kind":"journal","name":"Cancer treatment and research communications","route":"/journals/cancer-treatment-and-research-communications/"}]}}